MYMX
Mymetics Corporation
OTC Markets OTCPKUSDEQUITY
DELAYED
Last price
0.00
■ 0.00 (0.00%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
—
Prev close
0.00
Day high
0.00
Day low
0.00
Volume
100
Market cap
—
P/E (TTM)
—
52W range
0.00 – 0.00
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
0.00%
+1.4%
1M
0.00%
-3.7%
3M
0.00%
-3.1%
6M
0.00%
-11.1%
YTD
0.00%
-12.3%
1Y
0.00%
-20.0%
3Y
-100.00%
-174.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2022 | 2021 | YoY |
|---|---|---|---|
| Total revenue | $3.00K | $3.00K | 0.0% |
| Operating revenue | $3.00K | $3.00K | 0.0% |
| Cost of revenue | $1.44M | $975.00K | +47.9% |
| Gross profit | -$1.44M | -$972.00K | -48.0% |
| Research & development | — | $975.00K | — |
| Selling, general & admin | $1.33M | $1.10M | +20.5% |
| Total operating expense | $306.00K | $678.00K | -54.9% |
| Operating income | -$1.75M | -$1.65M | -5.8% |
| Net interest income | -$2.80M | -$2.75M | -1.8% |
| Pre-tax income | -$4.80M | -$4.73M | -1.6% |
| Tax provision | $0 | $0 | — |
| Net income | -$4.80M | -$4.73M | -1.6% |
| Net income to common | -$4.80M | -$4.73M | -1.6% |
| Basic EPS | -40.00 | -40.00 | 0.0% |
| Diluted EPS | -40.00 | -40.00 | 0.0% |
| EBIT | -$2.00M | -$1.98M | -1.3% |
| EBITDA | -$1.99M | -$1.96M | -1.5% |
| Basic shares | 151.88K | 151.88K | 0.0% |
| Diluted shares | 151.88K | 151.88K | 0.0% |
| Line item | 2022 | 2021 | YoY |
|---|---|---|---|
| Cash & equivalents | $313.00K | $571.00K | -45.2% |
| Cash & short-term investments | $313.00K | $571.00K | -45.2% |
| Accounts receivable | $62.00K | $15.00K | +313.3% |
| Total current assets | $481.00K | $673.00K | -28.5% |
| Property, plant & equipment | $159.00K | $278.00K | -42.8% |
| Goodwill & intangibles | $6.67M | $6.67M | 0.0% |
| Total assets | $7.32M | $7.63M | -4.1% |
| Total current liabilities | $72.03M | $67.43M | +6.8% |
| Current debt | $71.70M | $67.27M | +6.6% |
| Long-term debt | $156.00K | $162.00K | -3.7% |
| Total debt | $72.00M | $67.67M | +6.4% |
| Total liabilities | $72.22M | $67.72M | +6.6% |
| Shareholder equity | -$64.90M | -$60.09M | -8.0% |
| Working capital | -$71.55M | -$66.75M | -7.2% |
| Net tangible assets | -$71.57M | -$66.76M | -7.2% |
| Shares issued | 151.88K | 151.88K | 0.0% |
| Line item | 2022 | 2021 | YoY |
|---|---|---|---|
| Net income | -$4.80M | -$4.73M | -1.6% |
| Depreciation & amortisation | $15.00K | $19.00K | -21.1% |
| Change in working capital | $3.10M | $3.01M | +3.0% |
| Capital expenditure | -$2.00K | -$10.00K | +80.0% |
| Investing cash flow | -$2.00K | -$10.00K | +80.0% |
| Financing cash flow | $1.44M | $1.20M | +19.7% |
| Free cash flow | -$1.69M | -$1.71M | +1.1% |
| End cash position | $313.00K | $571.00K | -45.2% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.00
-0.00% from price
SMA 20
0.00
0.00% from price
SMA 50
0.00
0.00% from price
SMA 100
0.00
-0.00% from price
SMA 200
0.00
0.00% from price
EMA 12
0.00
-0.00% from price
EMA 26
0.00
-0.00% from price
EMA 50
0.00
-0.00% from price
RSI (14)
0.0
Oversold
MACD (12,26,9)
-0.00
Hist 0.00
ATR (14)
0.00
—
Realised vol 30D
0.0%
Annualised
Bollinger upper
0.00
20, 2σ
Bollinger lower
0.00
20, 2σ
50 / 200 cross
Death
0.00 vs 0.00
Trend bias
Below 200
0.00%
Risk profile
Beta vs SPY
0.00
Less volatile than market
Correlation to SPY
—
—
Realised vol 30D
0.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
0.0%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.00
Average true range
Beta (reported)
—
5Y monthly, from filing
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.